Boffa, Giacomo
Bruschi, Nicolò
Cellerino, Maria
Lapucci, Caterina
Novi, Giovanni
Sbragia, Elvira
Capello, Elisabetta
Uccelli, Antonio
Inglese, Matilde
Article History
First Online: 19 March 2020
Compliance with Ethical Standards
:
: No sources of funding were received for the conduct of this study or the preparation of this article.
: Giacomo Boffa, Nicolò Bruschi, Maria Cellerino, Giovanni Novi, Elvira Sbragia and Elisabetta Capello have no conflicts of interest that are directly relevant to the content of this study. Caterina Lapucci received honoraria for travel expenses for attending meetings from Genzyme and Roche. Antonio Uccelli received grants and contracts from the Italian Multiple Sclerosis Society Foundation (FISM), Novartis, Fondazione Cariplo, and the Italian Ministry of Health and received honoraria or consultation fees from Biogen, Roche, Teva, Merck, Genzyme and Novartis. Matilde Inglese received grants from the National Institutes of Health, National Multiple Sclerosis Society and FISM and received fees for consultation from Roche, Genzyme, Merck, Biogen and Novartis.
: This study was approved by the local ethical committee (Comitato Etico Regionale Liguria, San Martino).
: All patients signed a written informed consent before the study.